Testimony from a former Theranos product manager has shed light on the startup’s race to court investors and business partners and shortcuts it took when its blood-testing devices failed.
Read More
Testimony from a former Theranos product manager has shed light on the startup’s race to court investors and business partners and shortcuts it took when its blood-testing devices failed.
Read More